1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Revenio Group Oyj
  6. News
  7. Summary
    REG1V   FI0009010912

REVENIO GROUP OYJ

(REG1V)
  Report
Real-time Estimate Cboe Europe  -  05/23 08:25:48 am EDT
46.15 EUR   -0.50%
02:31aREVENIO GROUP CORPORATION : Managers' Transactions – Ari Isomäki
AQ
05/20REVENIO GROUP CORPORATION : Managers' Transactions – Heli Huopaniemi
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Arne Boye Nielsen
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Revenio Oyj : Group Corporation to transfer shares related to the share-based incentive scheme for 2018-2020

02/15/2021 | 08:00am EDT

Revenio Group Corporation, Stock Exchange Release, 15.2.2021 at 15:00

Revenio Group Corporation to transfer shares related to the share-based incentive scheme for 2018-2020

The Board of Directors of Revenio Group Corporation decided, on 15 February 2021, on the basis of the share issue authorisation granted to the Board of Directors by the company's Annual General Meeting held on 8 June 2020, to issue shares in a directed share issue without payment to pay the shares earned by the company’s key persons during the performance period 2018-2020 of the share-based incentive scheme.

The shares to be issued in the directed share issue without payment are issued in accordance with the terms and conditions of the company's current share-based incentive scheme to enhance the stability and work motivation of personnel, and thus there is an especially weighty financial reason for the share issue and for the derogation of the pre-emptive right of shareholders as provided in Chapter 9, Section 4(1) of the Finnish Limited Liability Companies Act. The establishment and main terms and conditions of the share-based incentive scheme were announced in a stock exchange release published on 20 April 2018 and on the company’s website.

A total of 12 253 of the company’s treasury shares will be transferred in a directed issue free of charge to persons included in the share-based incentive scheme. After the transfers, the company holds 118 805 treasury shares.

Revenio Group Corporation
Board of Directors

For further information, please contact:
CEO Jouni Toijala, tel. +358 50 484 0085
jouni.toijala@revenio.fi

CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi

www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki Ltd
Financial Supervisory Authority
Main media
www.revenio.fi

Revenio Group in brief
Revenio is an internationally operating health technology corporation and a globally leading supplier of ophthalmic devices. Revenio Group's eye diagnostics solutions include tonometers, retinal imaging apparatus and perimeters under the iCare brand. The main tool for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

The Revenio Group consists of Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy.

In 2020, Revenio Group's net sales totalled EUR 61.1 million, with its net operating profit standing at 17.1%. Revenio Group Corporation's shares are listed on Nasdaq Helsinki with the trading code REG1V.

© Modular Finance, source Nordic Press Releases

All news about REVENIO GROUP OYJ
02:31aREVENIO GROUP CORPORATION : Managers' Transactions – Ari Isomäki
AQ
05/20REVENIO GROUP CORPORATION : Managers' Transactions – Heli Huopaniemi
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Arne Boye Nielsen
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Ann-Christine Sundell
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Bill Östman
AQ
05/11REVENIO GROUP CORPORATION : Transfer of the Company's own shares
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Riad Sherif
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Pekka Tammela
AQ
04/28TRANSCRIPT : Revenio Group Oyj, Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28Revenio Group Corporation's Vice Chairman has been elected
AQ
More news
Financials
Sales 2022 93,8 M 99,0 M 99,0 M
Net income 2022 22,1 M 23,3 M 23,3 M
Net cash 2022 11,5 M 12,1 M 12,1 M
P/E ratio 2022 55,2x
Yield 2022 0,83%
Capitalization 1 232 M 1 300 M 1 300 M
EV / Sales 2022 13,0x
EV / Sales 2023 10,8x
Nbr of Employees 184
Free-Float 80,0%
Chart REVENIO GROUP OYJ
Duration : Period :
Revenio Group Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REVENIO GROUP OYJ
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 46,38 €
Average target price 49,13 €
Spread / Average Target 5,92%
EPS Revisions
Managers and Directors
Jouni Erik Toijala President & Chief Executive Officer
Robin Allan Pulkkinen Chief Financial Officer
Arne Boye Nielsen Chairman
Mika Salkola Director-Research & Development
Ari Isomäki Operations Director
Sector and Competitors
1st jan.Capi. (M$)
REVENIO GROUP OYJ-16.51%1 300
SARTORIUS AG-36.47%23 746
BIOTAGE AB (PUBL)-26.98%1 267
VAREX IMAGING CORPORATION-30.24%877
CELLAVISION AB (PUBL)5.78%824
908 DEVICES INC.-44.53%451